comparemela.com
Home
Live Updates
Bayer Janssen - Breaking News
Pages:
5
6
7
8
9
10
11
Latest Breaking News On - Bayer janssen - Page 4 : comparemela.com
Apixaban Again Linked to Less Bleeding in AF Patients
The observational findings from more than 500,000 patients suggest once more that apixaban may be the safest DOAC.
United states
United kingdom
Lana castellucci
Daiichi sankyo
Walliscy lau
Bayer janssen
Bristol myers squibb
Boehringer ingelheim
Md university of ottawa
Phd university college london
University college london
Internal medicine
Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest
The study is the latest showing apixaban may be the safest of the DOACs when it comes to bleeding, say experts.
United states
Ghadeerk dawwas
Neena abraham
Daiichi sankyo
Bayer janssen
Bristol myers squibb
American heart association
Heart rhythm society
University of pennsylvania perelman school medicine
American college of cardiology
Boehringer ingelheim
Internal medicine
Pennsylvania perelman school
Mayo clinic
American college
Not ready
RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion
The idea of preserving the radial artery for future needs, including CABG and hemodialysis, is important, Roxana Mehran says.
New york
United states
Rania hammami
Shrilla banerjee
Roxana mehran
Bayer janssen
Hedi chaker hospital
Intriguing findings require
Icahn school
Mount sinai
Sussex healthcare
More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF
Investigators were “floored by the results,” and can’t understand why the DOAC was linked with higher mortality.
United states
New delhi
Comunidad autonoma de cataluna
Rivaroxaban xarelto
Ganesan karthikeyan
Salim yusuf
Bayer janssen
Md university of liverpool
European society of cardiology
Dphil mcmaster university population health research institute
Md all india institute of medical sciences
Hot line
European society
New england journal
Population health research institute
All india institute
INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF
(UPDATED) Investigators were “floored by the results,” and can’t understand why the DOAC was linked with higher mortality.
United states
New delhi
Comunidad autonoma de cataluna
Rivaroxaban xarelto
Los angeles
Renato lopes
Kalyanam shivkumar
Ganesan karthikeyan
Salim yusuf
Bayer janssen
Md university of liverpool
European society of cardiology
Dphil mcmaster university population health research institute
Md duke clinical research institute
Md all india institute of medical sciences
Hot line
vimarsana © 2020. All Rights Reserved.